FIOCRUZ
Rio de Janeiro, Rio de Janeiro, Brazil
Purpose
to help the implementation of G6PD testing in populations from vivax malaria endemic areas eligible to use tafenoquine, a new single-dose, radical-cure drug
Division
Global Health
Date
November 2017
Region Served
AMERICA
Committed amount
$617,100
Grant topic
Malaria
Duration (months)
38
Grantee location
Rio de Janeiro, Rio de Janeiro, Brazil
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.